Research ArticleCancer therapy

Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors

See allHide authors and affiliations

Sci. Signal.  27 Jun 2017:
Vol. 10, Issue 485, eaak9916
DOI: 10.1126/scisignal.aak9916

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article